公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.
公司地址 2265 Upper Middle Road East, Suite 602, Oakville, ON, CAN, L6H 0G5
電話號碼 +1 289 910-0850
傳真號碼 --
公司網頁 https://www.cardiolrx.com
員工數量 23
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Christopher J. Waddick, C.A.,C.P.A.,M.B.A. Director, Chief Financial Officer and Corporate Secretary 美元 220.00K 31/03/2026
Mr. David G. Elsley, M.B.A. Director, President and Chief Executive Officer 美元 525.00K 31/03/2026
Dr. Andrew Hamer, M.D. Chief Medical Officer and Head, Research and Development 美元 576.62K 31/03/2026
Mr. Bernard Lim Chief Operating Officer 美元 385.00K 31/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Christopher J. Waddick, C.A.,C.P.A.,M.B.A. Director, Chief Financial Officer and Corporate Secretary 31/03/2026
Mr. David G. Elsley, M.B.A. Director, President and Chief Executive Officer 31/03/2026
Ms. Jennifer Chao Independent Director 31/03/2026
Mr. Peter Pekos, B.Sc. ,M.Sc. Independent Director 31/03/2026
Dr. Guillermo Torre-Amione, M.D.,PhD Chairman of the Board 31/03/2026
Mr. Colin G. Stott Independent Director 31/03/2026
Ms. Teri Loxam, M.B.A. Independent Director 31/03/2026
Dr. Timothy John Garnett, M.B.B.S. Independent Director 31/03/2026
 
所屬ETF (更新日期: 07/11/2026 04:45)
代號 名稱 佔比% ▼ 持有日期
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.08%30/10/2026
YOLOAdvisorShares Pure Cannabis ETF<0.000001%23/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.